High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer

PURPOSE: High-dose-rate (HDR) brachytherapy has been accepted as an effective and safe method to treat prostate cancer. The aim of this study was to describe acute toxicity following HDR brachytherapy to the prostate, and to examine the association between dosimetric parameters and urinary toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Cendales, Ricardo, Alwers, Elizabeth, Cifuentes, Javier, Bobadilla, Ivan, Torres, Felipe, Arbelaez, Juan, Gaitan, Armando, Cortes, Helber, Acevedo, Yenny, Quintero, Paulo, Vasquez, Jaider
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371062/
https://www.ncbi.nlm.nih.gov/pubmed/25829931
http://dx.doi.org/10.5114/jcb.2015.48838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371062/
https://www.ncbi.nlm.nih.gov/pubmed/25829931
http://dx.doi.org/10.5114/jcb.2015.48838

Ejemplares similares